Complex treatment of patients with lung cancer: results

Development and manifistation of lymphotropic drug administration as a component of complex postoperative therapy in patients with lung cancer is topical. Objective. The aim of the paper is to analyze the results of complex postoperative treatment of patients with lung cancer. Materials and Methods. A total of 280 patients, aged 39-75, were examined during the postoperative period. All of them had lung cancer and were operated on in 2010-2016. The patients underwent pneumonectomy, lobectonomy, bilobectomy, or lymphodissection. Patients were divided into three groups. In the first group (n=206) only routine treatment was used. In the second group (n=44), along with routine treatment, lymphotropic interspinal drugs were injected. In the third group (n=30), along with routine treatment, lymphotropic drugs were administered according to a newly developed method. Results. The newly developed method of lymphotropic therapy decreased the severity of pain (1.8 times) and duration of pain (2 times) during the postoperative period in patients with lung cancer in comparison with traditional treatment. Besides, lymphotropic administration of drugs has made it possible to reduce the duration of inpatient treatment from 17.1±0.2 and 16.4±0.3 days (in the first and second groups, respectively) up to 10.2±0.3 days (p